Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity
- 1 June 2022
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 45 (7) , 703-712
Abstract
Proton pump inhibitors are widely used in the treatment of various acid-related diseases and are among the most commonly used drugs. Studies estimate that 25–70% of proton pump inhibitors are prescribed for inappropriate treatments, doses, and indications, where the benefits of proton pump inhibitor use may be less than the risk of adverse drug reactions for many patients. Acute interstitial nephritis is an immune-mediated atypical kidney injury in the long-term use of proton pump inhibitors that causes problems for clinicians and patients. In this review, we summarize the current knowledge of proton pump inhibitors inducing acute interstitial nephritis, chronic kidney disease, and even end-stage renal disease in terms of incidence, pathogenesis, factors, clinical features, and diagnosis. We discuss how these factors change under conditions of acute interstitial nephritis, chronic kidney disease, and end-stage renal disease. The purpose of this review is to assess the current evidence to help clinicians and patients interpret the potential causal relationship between proton pump inhibitor intake and nephrotoxicity. This prompts clinicians to consider the appropriate dose and duration of proton pump inhibitor therapy to avoid inappropriate use.Keywords
Funding Information
- The University Synergy Innovation Program of Anhui Province (GXXT-2021-064)
- The Enhancement Programme for Basic and Clinical Cooperative Research of Anhui Medical University (2019xkjT016)
- The joint project of nephrology and pharmacology at anhui medical university (2021CXK012)
- The Key Project Foundation of Natural Science Research in Universities of Anhui Province in China (KJ2021A0329)
- the Foundation of Anhui Medical University (2018xkj065)
This publication has 69 references indexed in Scilit:
- Unexpected Effect of Proton Pump InhibitorsCirculation, 2013
- Acute interstitial nephritis due to proton pump inhibitorsIndian Journal of Nephrology, 2013
- Overprescribing proton pump inhibitorsBMJ, 2008
- Proton pump inhibitors and the kidney: critical reviewClinical Nephrology, 2007
- Proton pump inhibitor‐induced acute interstitial nephritisBritish Journal of Clinical Pharmacology, 2007
- Acute kidney injury following proton pump inhibitor therapyKidney International, 2007
- Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 casesNephrology, 2006
- Rabeprazole‐induced acute interstitial nephritisNephrology, 2005
- Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unitNephrology Dialysis Transplantation, 2004
- Toxicity study of a rubber antioxidant, 2-mercaptobenzimidazole, by repeated oral administration to rats.The Journal of Toxicological Sciences, 1998